The company, which operates 27 hospital facilities across 12 states, saw its diluted earnings per share climb to $15.87 for the six-month period ending June 30. While total revenue dipped 6.3% to $427.2 million—a decline management linked to the normalization of Independent Dispute Resolution (IDR) outcomes—the firm successfully lowered its operating costs to $194.2 million from $212.5 million in the prior-year period.

Financial gains were bolstered by a retroactive amendment to an agreement with HaloMD and a reduction in CMS administrative fees. These regulatory and contractual shifts are expected to lower normalized contract services expenses by 25% to 30% moving forward. Despite the revenue softening, patient volume remained resilient, with total hospital visits rising 6.2% to 99,704. Looking ahead, CFO Jon Bates confirmed the company maintains a strong balance sheet with $205.2 million in cash and plans to expand its footprint with three new hospital openings before the end of the year.